Mediators of Inflammation / 2014 / Article / Tab 1

Research Article

Response to Statin Therapy in Obstructive Sleep Apnea Syndrome: A Multicenter Randomized Controlled Trial

Table 1

Baseline characteristics of placebo and statin patients.

Placebo Statin value

2625
Age (years)56 ± 9 51 ± 12 NS
Male gender (%)7384NS
BMI (kg/m²)28.70 ± 3.94 28.28 ± 5.12 NS
History
 Smoking (%)50.060.0NS
 Alcohol (%)38.556.0NS
 Diabetes (%)0.04.0NS
 Dyslipidemia (%) 3.912.0NS
Respiratory characteristics
 AHI (n/h)45.47 ± 13.10 43.26 ± 19.19 NS
 Mean SaO2 (%)92.57 ± 1.44 92.70 ± 2.40 NS
 SaO2 < 90% (%)10.33 ± 13.20 11.66 ± 18.11 NS
Clinical BP
 SBP (mmHg)127.67 ± 15.27 127.78 ± 15.07 NS
 DBP (mmHg)79.02 ± 11.61 79.16 ± 11.60 NS
 MAP (mmHg) 95.22 ± 11.9395.37 ± 12.21NS
 HR (bpm) 63 ± 8 64 ± 10 NS
Biological parameters
 Total cholesterol (g/L)2.25 ± 0.64 2.46 ± 0.94 NS
 LDL cholesterol (g/L)1.41 ± 0.45 1.60 ± 0.67 NS
 HDL cholesterol (g/L)0.54 ± 0.23 0.74 ± 0.52*0.011
  Triglycerides (g/L)1.55 ± 1.10 1.16 ± 0.59 NS

Data are mean ± SD or percentage. BMI, body mass index; SaO2, oxygen saturation; SaO2 < 90%, percentage of recording time spent at a SaO2 < 90%; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein; HDL, high-density lipoprotein; HR, heart rate. by Student or Mann-Whitney test. For qualitative data, a Chi-2 test or a Fisher test was performed. NS, not significant.